PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2012

Oct 22, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2012-10-18

Reporting Person: Malley Thomas (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-18	STOCK OPTION (RIGHT TO BUY)	$16.50	A	10000	Acquired	2022-10-18	COMMON STOCK (10000)	Direct
2012-10-18	STOCK OPTION (RIGHT TO BUY)	$16.50	A	10000	Acquired	2022-10-18	COMMON STOCK (10000)	Direct

Footnotes

F1: The vesting commencement date of the option is October 18, 2012. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the vesting commencement date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the vesting commencement date thereafter, subject to the Reporting Person's continued service through each vesting date as a member of the Compensation Committee of the Board of Directors of the Issuer.

F2: The vesting commencement date of the option is October 18, 2012. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the vesting commencement date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the vesting commencement date thereafter, subject to the Reporting Person's continued service through each vesting date as a member of the Nominating and Corporate Governance Committee of the Board of Directors of the Issuer.